DOCN (DOCN)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$13.89B
EV / Sales14.65
EV / EBITDA33.32
EV / Operating Cash Flow47.51
EV / Free Cash Flow1310.59

Return Metrics (TTM)

Return on Equity (ROE)154.32%
Return on Assets (ROA)9.21%
Return on Invested Capital (ROIC)6.49%
Return on Capital Employed (ROCE)8.11%

Yield Metrics

Earnings Yield2.17%
Free Cash Flow Yield0.08%

Balance Sheet Strength

Net Debt / EBITDA0.38
Current Ratio1.46
Working Capital$297.32M
Tangible Asset Value$439.04M
Net Current Asset Value-$738.72M

Working Capital Efficiency

Days Sales Outstanding40.58
Days Payables Outstanding29.56
Operating Cycle (Days)40.58
Cash Conversion Cycle11.01

Capital Allocation

CapEx / Revenue29.71%
CapEx / Operating Cash Flow96.37%
R&D / Revenue18.01%
SG&A / Revenue24.04%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin59.86%
Operating Margin17.42%
Net Profit Margin28.76%

Solvency

Debt / Equity-25.46
Quick Ratio0.69
Cash Ratio0.41

Per Share

Revenue / Share$9.85
FCF / Share$0.45
PE Ratio17.00